Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL Β-GLUCURONIDASE ENZYMES INDUSTRY
2.1 Summary about β-Glucuronidase Enzymes Industry
2.2 β-Glucuronidase Enzymes Market Trends
2.2.1 β-Glucuronidase Enzymes Production & Consumption Trends
2.2.2 β-Glucuronidase Enzymes Demand Structure Trends
2.3 β-Glucuronidase Enzymes Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Above 90%
4.2.2 Above 95%
4.2.3 Above 99%
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Biopharmaceutical Companies
4.3.2 Hospitals
4.3.3 Bioscience Research Institutions
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Above 90%
5.2.2 Above 95%
5.2.3 Above 99%
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Biopharmaceutical Companies
5.3.2 Hospitals
5.3.3 Bioscience Research Institutions
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Above 90%
6.2.2 Above 95%
6.2.3 Above 99%
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Biopharmaceutical Companies
6.3.2 Hospitals
6.3.3 Bioscience Research Institutions
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Above 90%
7.2.2 Above 95%
7.2.3 Above 99%
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Biopharmaceutical Companies
7.3.2 Hospitals
7.3.3 Bioscience Research Institutions
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Above 90%
8.2.2 Above 95%
8.2.3 Above 99%
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Biopharmaceutical Companies
8.3.2 Hospitals
8.3.3 Bioscience Research Institutions
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Above 90%
9.2.2 Above 95%
9.2.3 Above 99%
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Biopharmaceutical Companies
9.3.2 Hospitals
9.3.3 Bioscience Research Institutions
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 R&D Systems(US)
10.1.2 Novus Biologicals(US)
10.1.3 Abcam(UK)
10.1.4 Boster Biological Technology(US)
10.1.5 Thermo Fisher Scientific(US)
10.1.6 Santa Cruz Biotechnology(US)
10.1.7 RayBiotech(US)
10.1.8 Origene(US)
10.1.9 Lifespan Biosciences(US)
10.1.10 USBiological(US)
10.1.11 Proteintech(US)
10.1.12 Genetex(US)
10.1.13 Biobyt(UK)
10.1.14 Aviva Systems Biology Corporation(US)
10.1.15 Fitzgerald Industries International(US)
10.1.16 Atlas Antibodies(SE)
10.1.17 Abbexa Ltd(UK)
10.1.18 Bio-Rad(US)
10.1.19 Bioss Antibodies(US)
10.1.20 St Johns Laboratory Ltd(UK)
10.2 β-Glucuronidase Enzymes Sales Date of Major Players (2017-2020e)
10.2.1 R&D Systems(US)
10.2.2 Novus Biologicals(US)
10.2.3 Abcam(UK)
10.2.4 Boster Biological Technology(US)
10.2.5 Thermo Fisher Scientific(US)
10.2.6 Santa Cruz Biotechnology(US)
10.2.7 RayBiotech(US)
10.2.8 Origene(US)
10.2.9 Lifespan Biosciences(US)
10.2.10 USBiological(US)
10.2.11 Proteintech(US)
10.2.12 Genetex(US)
10.2.13 Biobyt(UK)
10.2.14 Aviva Systems Biology Corporation(US)
10.2.15 Fitzgerald Industries International(US)
10.2.16 Atlas Antibodies(SE)
10.2.17 Abbexa Ltd(UK)
10.2.18 Bio-Rad(US)
10.2.19 Bioss Antibodies(US)
10.2.20 St Johns Laboratory Ltd(UK)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT